CRDMOs Transform Early Drug Development with Seamless Integration of Translational & Clinical Research
How India is Becoming the Next Clinical Research Destination
Advancing Innovation in a New Era of Drug Development
Syngene at CPHI Frankfurt
Syngene International Closes 2025 with Firm Foundation in Baltimore, Looks Ahead to a Strong 2026
From curiosity to careers: How early STEM engagement shapes aspirations in underserved communities
Technology’s Role in Strengthening Quality Culture in Indian CDMOs
How a change of tone changed the way people saw me
Advanced bioprocessing capabilities form a core pillar of Syngene’s growth strategy
Future of drug development lies in eliminating the boundaries between discovery and clinical execution
